www.bionand.es

ALEMANIA

• Investigador responsable: Ernst Wagner
  Organismo: Ludwig-Maximilians University of Munich
  Centro/Facultad: Center for Drug Research, Pharmaceutical Biology - Biotechnology
  Grupo/Departamento: Pharmacy
  Ciudad: Munich
  Líneas de investigación: Nucleic acid based therapeutics: development of nonviral vectors, targeting strategies. Therapeutic strategies: synthetic double stranded RNA for Glioblastoma treatment, tumor angiogenesis, Culture Models of Colorectal Cancer

  web: www.cup.uni-muenchen.de/dept/ph/pharmabio/e_wagner.php

• Investigador responsable: Wolfgang Parak
  Organismo: University of Marburg
  Centro/Facultad: Faculty of Physics
  Grupo/Departamento: Biophotonics
  Ciudad: Marburg
  Líneas de investigación: Synthesis, characterization and Biological applications of polyelectrolyte polymer capsules and colloidal nanoparticles // Interaction of nanoparticles with cells

  web: www.physik.uni-marburg.de/en/research/biophotonics-group/home.html
   

• Investigador responsable: Claus-Michael Lehr
  Organismo: Saarland University
  Centro/Facultad: Faculty of Pharmacy
  Grupo/Departamento: Biopharmaceutics and Pharmaceutical Technology
  Ciudad: Saarbrücken
  Líneas de investigación: Nanoparticulate carrier system for targeted drug delivery // Study of the biocompatibility and biotoxicity of nanoparticles // New technologies to improve the transport of drugs across biological barriers

  web: http://archiv.uni-saarland.de/de/fakultaeten/fak8/fr82/lehr
   

CANADA

• Investigador responsable: Warren Chan
  Organismo: University of Toronto
  Centro/Facultad: Institute of Biomaterials and Biomedical Engineering
  Grupo/Departamento: Integrated Nanotechnolgy & Biomedical Science Lab
  Ciudad: Toronto
  Líneas de investigación: Cell's molecular dynamics by using recent developments in Nanotechnology, Microtechnology and Molecular Engineering

  web: http://inbs.med.utoronto.ca/
   

EEUU

• Investigador responsable: Lajos Balogh
  Organismo: University of Buffalo
  Grupo/Departamento: Radiation Medicine
  Ciudad: Buffalo, New York
  Líneas de investigación: Development of radioactive nanocomposites to treat tumor. Imaging nanocomposites targeting tumor microvasculature
   
• Investigador responsable: Raoul Kopelman
  Organismo: University of Michigan
  Centro/Facultad: Chemistry Department
  Grupo/Departamento: Kopelman Laboratory
  Ciudad: Ann Arbor, Michigan
  Líneas de investigación: Development of biochemical nano-sensors, energy transducer supermolecules (artificial photosynthetic antenna), and in-vivo chemical measurements in brain cells. Novel molecular nano-explorer devices for the early detection and therapy of cancer

  web: http://www.umich.edu/~koplab/index.htm
   

FRANCIA

• Investigador responsable: Patrick Couvreur
  Organismo: Université Paris-SUD 11
  Centro/Facultad: Lab of Physico-chimie, Pharmacotechnie et Biopharmacie
  Grupo/Departamento: Group of Drug Targeting in Cancer
  Ciudad: París
  Líneas de investigación: Systems for drug targeting (nanospheres) // New nanotechnologies for brain targeting

  web: http://www.umr-cnrs8612.u-psud.fr/EN/KitSC/pres_eq7.htm
   

• Investigador responsable: Chantal Larpent
  Organismo: Versailles-Saint-Quentin-en-Yvelines University
  Centro/Facultad: Lavoisier Institute
  Grupo/Departamento: Group of Reactivity and Catalysis
  Ciudad: Versalles
  Líneas de investigación: Synthesis and applications as nanosensors and in nanomaterials science

  web:http://www.ilv.uvsq.fr/research/Echo/echo.htm
  

ISRAEL

• Investigador responsable: Machluf Marcelle
  Centro/Facultad: Israel Institute of Technology
  Grupo/Departamento: Biotechnology and Food Engineering Department
  Ciudad: Haifa
  Líneas de investigación: Developing nano-particles for the delivery of anti cancer drugs to the brain and other organ, Developing nano-delivery system for DNA vaccination, Tissue engineering of heart and blood vessels

  web:http://biotech.technion.ac.il/Members/Machluf.html

ITALIA

• Investigador responsable: M. Francesca Casula
  Organismo: University of Cagliari
  Centro/Facultad: Faculty of Pharmacy
  Grupo/Departamento: Chemical Science
  Ciudad: Cagliari
  Líneas de investigación: Design and synthesis of nanostructured materials
  web: http://www.unica.it/~corrias/maria/mariac.htm
  

• Investigador responsable: Liberato Manna
  Centro/Facultad: Istituto Italiano di Tecnologia
  Grupo/Departamento: Nanochemistry Facility
  Ciudad: Genova
  Líneas de investigación: Synthesis, structural characterization and modelling of the growth of inorganic nanostructures
  web: http://www.iit.it/it/people.html?view=profile&layout=profile&id=203
  

JAPON

• Investigador responsable: Kazunori Kataoka
  Organismo: University of Tokyo
  Centro/Facultad: Global COE Center for Medical System Innovation
  Grupo/Departamento: Kataoka Laboratory
  Ciudad: Tokio
  Líneas de investigación: Nanocarriers for drug delivery and gene delivery

  web: http://www.material.t.u-tokyo.ac.jp/material_e/contents/faculty/kataoka.html

PAISES BAJOS

• Investigador responsable: Andreas Herrmann
  Organismo: University of Groningen
  Centro/Facultad: Zernike Institute for Advanced Materials
  Grupo/Departamento: Polymer Chemistry and Bioengineering
  Ciudad: Groningen
  Líneas de investigación: Aplication of micelles to treat cancer diseases

  web: http://www.rug.nl/staff/a.herrmann/index
   

• Investigador responsable: Gert Storm
  Organismo: Utrecht University
  Centro/Facultad: Utrecht Institute for Pharmaceutical Sciences
  Grupo/Departamento: Pharmaceutics
  Ciudad: Utrecht
  Líneas de investigación: Nanocarriers for drug delivery

   

PORTUGAL

• Investigador responsable: Ricardo Franco
  Organismo: Universidade Nova de Lisboa
  Centro/Facultad: Faculdade de Ciências e Tecnologia
  Grupo/Departamento: REQUIMTE/CQFB
  Ciudad: Caparica
  Líneas de investigación: Tyrosinase as an environmental sensor for phenols and pesticides // Development of a nanotechnology-based biosensor for Malaria detection in clinical samples
  web: http://www.dq.fct.unl.pt/nanobiotechnologylab/
   
• Investigador responsable: João F. Mano
  Organismo: University of Minho
  Centro/Facultad: Department of Polymer Engineering
  Grupo/Departamento: 3B’s Research Group
  Ciudad: Guimarães
  Líneas de investigación: Biomacromolecular-based systems for biomedical applications, including tissue engineering scaffolding and drug delivery
  web: http://www.hippocratesproject.org/index.php?option=com_content&task=view&id=7&Itemid=4
   

REINO UNIDO

• Investigador responsable: Kostas Kostarelos
  Organismo: University of London
  Centro/Facultad: School of Pharmacy
  Grupo/Departamento: Nanomedicine Lab, Center for Drug Delivery
  Ciudad: Londres
  Líneas de investigación: Carbon Nanomaterials // Cancer Delivery Systems // Pharmaceutical Nanomaterials // Gene therapy vectors

  web: http://www.pharmacy.ac.uk/kostas_kostarelos.html
   

• Investigador responsable: Thomas Nann
  Organismo: University of East Anglia
  Centro/Facultad: School of Chemical Sciences and Pharmacy
  Grupo/Departamento: Chemestry
  Ciudad: Norwich
  Líneas de investigación: Synthesis and characterization of nanomaterials // Synthesis of inorganic/polymeric hybrid nanocrystals. Bioimaging using luminescent nanocrystals. Coupling and application of nanoparticles to biomolecules

  web: http://www.uea.ac.uk/che/people/faculty/nannt
  
  

• Investigador responsable: Duncan Q. M. Craig
  Organismo: University of East Anglia
  Centro/Facultad: School of Chemical Sciences and Pharmacy
  Grupo/Departamento: Pharmacy
  Ciudad: Norwich
  Líneas de investigación: Development of novel approaches to the characterisation and design of drugs and drug delivery systems

  web: http://www.uea.ac.uk/pha/phapeople/phafaculty/craigd
   

 ALEMANIA

• Centro: Center for Biomedical Nanotechnology
  Organismo: Charité - Universitätsmedizin Berlin
  Persona de contacto: Andreas Jordan
  Ciudad: Berlín
  Líneas de investigación: Magnetic nanoparticles for application in RF-magnetic hyperthermia

  web: http://www.charite.de/cbn/CBN%20Homepage%20v.2.0/CBN%20ordner/CBN/index.html

EEUU

• Centro/Facultad: The National Dendrimer & Nanotechnology Center
  Organismo: Central Michigan University
  Persona de contacto: Donald A. Tomalia
  Ciudad: Mount Pleasant, Michigan
  Líneas de investigación:
  • Drug encapsulation, release and disease targeting protocols are being established and tested for cancer therapy and anti-flammatory drug systems using a range of dendrimer carrier structures.
  • Researching cytotoxicity of dendrimers and other nanoscale structures.
  • The use of dendrimers as a catalyst in the production of carbon nanotubes at the lowest temperatures recorded.
  • The attachment of oligonucleotides to dendrimers for targeting, amplification or detection in biological systems.
  • Development of nuclear magnetic reagents which allow higher resolution and site specific targeting to disease or inflamation.
  • The stabilization of nano-crystals or quantum dots with unique optical, electronic or other properties for use in bio-labeling, and flat panel display technologies.
  • Development of lower-cost synthetic routes to new proprietary dendrimers and dendritic polymers.
  • Development of dendrimers as in-vivo nano-diagnostic agents and devices.

  web: http://www.dendrimercenter.org/